On August 19, 2010, HHS released a report entitled “The Public Health Emergency Medical Countermeasure Enterprise Review: Transforming the Enterprise to Meet Long Range National Needs.” Prepared in response to the H1N1 pandemic flu experience, the HHS report reviews the federal government’s role in producing medical countermeasures — medications, vaccines, equipment and supplies for a health emergency. Among other things, the report addresses the government’s need to: upgrade science and regulatory capacity at the FDA; quickly develop manufacturing processes that can be used for multiple medications or vaccines; help small, emerging biotech companies bring products to market; and identify promising research and facilitate its translation into vaccines, drugs, and treatments.